Inactive Instrument

Biondvax Pharmaceuticals Ltd Share Price

Stocks

End-of-day quote TEL AVIV STOCK EXCHANGE
- ^ILa	-

16/07/19	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
08/07/19	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
26/06/19	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
18/06/19	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
10/06/19	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	01/03/2021
Uri Ben-Or DFI	Director of Finance/CFO	55	31/12/2006
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	31/12/2021

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	29/09/2019
Samuel Moed BRD	Director/Board Member	64	23/03/2020
Adi Raviv BRD	Director/Board Member	71	23/03/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.11%	+2.71%	+0.44%	+26.85%	46.28B
IQVIA HOLDINGS INC.	-1.12%	+1.78%	+42.30%	+27.55%	43.85B
REVOLUTION MEDICINES, INC.	-3.04%	-6.29%	+338.56%	+515.97%	40.93B
BEONE MEDICINES AG	-0.74%	+1.25%	+4.92%	+67.98%	39.89B
CELLTRION, INC.	-0.50%	+0.67%	+10.29%	+41.28%	29.5B
MEDPACE HOLDINGS, INC.	-0.46%	+4.22%	+22.81%	+139.44%	17.09B
ASCENDIS PHARMA A/S	-0.97%	-10.17%	-	-	15.55B
EUROFINS SCIENTIFIC SE	-0.57%	+8.12%	+22.19%	+38.68%	15.22B
TEMPUS AI, INC.	-3.14%	+31.91%	-11.79%	-	14.05B
Average	-1.16%	+3.76%	+53.72%	+122.54%	29.15B
Weighted average by Cap.	-1.10%	+1.87%	+68.04%	+130.90%

Employees

Sector